The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Prime Medicine Inc’s current trading price is -83.43% away from its 52-week high, while its distance from the 52-week low is 22.87%. The stock’s price range for this period has been between $1.12 and $8.27 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.84 million for the day, a number notably lower than the average daily volume of 1.49 million over the last three months.
Prime Medicine Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $8.27 on 05/21/24, while the lowest price for the same period was registered at $1.12 on 04/09/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Prime Medicine Inc (PRME) has experienced a quarterly decline of -51.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 179.87M and boasts a workforce of 214 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.2105, with a change in price of -1.4350. Similarly, Prime Medicine Inc recorded 1,295,494 in trading volume during the last 100 days, posting a change of -51.43%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PRME stands at 1.13. Similarly, the long-term debt-to-equity ratio is also 1.07.
PRME Stock Stochastic Average
Prime Medicine Inc’s raw stochastic average for the past 50 days is presently 17.71%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 25.74%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 13.01% and 10.69%, respectively.
PRME Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -53.08% this year. Over the last six months, there has been a stronger performance of -68.29%. The price of PRME fallen by 10.48% during the last 30 days period. For the last 5-days stocks have improved 5.38%.
